pd168393 has been researched along with Neoplasms, Nerve Sheath in 1 studies
PD 168393 : A member of the class of quinazolines carrying bromoanilino and acrylamido substituents at positions 4 and 6 respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Malignant peripheral nerve sheath tumors (MPNSTs) are rapidly progressive Schwann cell neoplasms." | 1.38 | The pan erbB inhibitor PD168393 enhances lysosomal dysfunction-induced apoptotic death in malignant peripheral nerve sheath tumor cells. ( Byer, S; Carroll, SL; Kaza, N; Kohli, L; Lavalley, NJ; Roth, KA; Turner, KL, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kohli, L | 1 |
| Kaza, N | 1 |
| Lavalley, NJ | 1 |
| Turner, KL | 1 |
| Byer, S | 1 |
| Carroll, SL | 1 |
| Roth, KA | 1 |
1 other study available for pd168393 and Neoplasms, Nerve Sheath
| Article | Year |
|---|---|
The pan erbB inhibitor PD168393 enhances lysosomal dysfunction-induced apoptotic death in malignant peripheral nerve sheath tumor cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Autophagy; Caspases; Cell Line, Tumor; Ce | 2012 |